<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1038/s41551-020-00654-0</query><apiKey>87ba7cb21f89ce78154df796840621f4</apiKey><result><total>1</total><start>1</start><pageLength>2</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="publisher-id">41551</journal-id><journal-id journal-id-type="doi">10.1038/41551.2157-846X</journal-id><journal-title-group><journal-title>Nature Biomedical Engineering</journal-title><abbrev-journal-title abbrev-type="publisher">Nat Biomed Eng</abbrev-journal-title></journal-title-group><issn pub-type="epub">2157-846X</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s41551-020-00654-0</article-id><article-id pub-id-type="manuscript">654</article-id><article-id pub-id-type="doi">10.1038/s41551-020-00654-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/692/700/139/1512</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/639/925/350/354</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/38/77</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/38/90</subject></subj-group><subj-group subj-group-type="NatureArticleTypeID"><subject>article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6652-9394</contrib-id><name><surname>Cheong</surname><given-names>Jiyong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Yu</surname><given-names>Hojeong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Lee</surname><given-names>Chang Yeol</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Lee</surname><given-names>Jung-uk</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Choi</surname><given-names>Hyun-Jung</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au6"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9236-157X</contrib-id><name><surname>Lee</surname><given-names>Jae-Hyun</given-names></name><address><email>jhyun_lee@yonsei.ac.kr</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="corresp" rid="IDs41551020006540_cor6">f</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au7"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0087-0909</contrib-id><name><surname>Lee</surname><given-names>Hakho</given-names></name><address><email>hlee@mgh.harvard.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="corresp" rid="IDs41551020006540_cor7">g</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au8"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8948-5929</contrib-id><name><surname>Cheon</surname><given-names>Jinwoo</given-names></name><address><email>jcheon@yonsei.ac.kr</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="corresp" rid="IDs41551020006540_cor8">h</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.410720.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1784 4496</institution-id><institution content-type="org-division">Center for Nanomedicine</institution><institution content-type="org-name">Institute for Basic Science (IBS)</institution></institution-wrap><addr-line content-type="city">Seoul</addr-line><country country="KR">Republic of Korea</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.15444.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5454</institution-id><institution content-type="org-division">Graduate Program of Nano Biomedical Engineering (NanoBME), Advanced Science Institute</institution><institution content-type="org-name">Yonsei University</institution></institution-wrap><addr-line content-type="city">Seoul</addr-line><country country="KR">Republic of Korea</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution content-type="org-division">Center for Systems Biology</institution><institution content-type="org-name">Massachusetts General Hospital Research Institute</institution></institution-wrap><addr-line content-type="city">Boston</addr-line><addr-line content-type="state">MA</addr-line><country country="US">USA</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution content-type="org-division">Department of Radiology, Massachusetts General Hospital</institution><institution content-type="org-name">Harvard Medical School</institution></institution-wrap><addr-line content-type="city">Boston</addr-line><addr-line content-type="state">MA</addr-line><country country="US">USA</country></aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.15444.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5454</institution-id><institution content-type="org-division">Department of Chemistry</institution><institution content-type="org-name">Yonsei University</institution></institution-wrap><addr-line content-type="city">Seoul</addr-line><country country="KR">Republic of Korea</country></aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.14005.30</institution-id><institution-id institution-id-type="ISNI">0000 0001 0356 9399</institution-id><institution content-type="org-division">Department of Laboratory Medicine, Chonnam National University Hospital</institution><institution content-type="org-name">Chonnam National University Medical School</institution></institution-wrap><addr-line content-type="city">Gwangju</addr-line><country country="KR">Republic of Korea</country></aff></contrib-group><author-notes><fn fn-type="con"><p>These authors contributed equally: Jiyong Cheong, Hojeong Yu.</p></fn><corresp id="IDs41551020006540_cor6"><label>f</label><email>jhyun_lee@yonsei.ac.kr</email></corresp><corresp id="IDs41551020006540_cor7"><label>g</label><email>hlee@mgh.harvard.edu</email></corresp><corresp id="IDs41551020006540_cor8"><label>h</label><email>jcheon@yonsei.ac.kr</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>3</day><month>12</month><year>2020</year></pub-date><pub-date date-type="pub" publication-format="print"><month>12</month><year>2020</year></pub-date><volume>4</volume><issue seq="8">12</issue><fpage>1159</fpage><lpage>1167</lpage><history><date date-type="registration"><day>2</day><month>11</month><year>2020</year></date><date date-type="received"><day>17</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>1</day><month>11</month><year>2020</year></date><date date-type="online"><day>3</day><month>12</month><year>2020</year></date></history><pub-history><event event-type="Correction"><event-desc>A Correction to this paper has been published: https://doi.org/10.1038/s41551-020-00676-8.</event-desc><date><day>17</day><month>12</month><year>2020</year></date></event></pub-history><permissions><copyright-statement content-type="compact">© The Author(s), under exclusive licence to Springer Nature Limited 2020</copyright-statement><copyright-statement content-type="comment">corrected publication 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Author(s), under exclusive licence to Springer Nature Limited</copyright-holder></permissions><related-article related-article-type="correction-forward" ext-link-type="doi" xlink:href="10.1038/s41551-020-00676-8"/><abstract xml:lang="en" id="Abs1"><title>Abstract</title><p id="Par1">The diagnosis of severe acute respiratory syndrome 2 (SARS-CoV-2) infection by quantitative PCR with reverse transcription (RT–qPCR) typically involves bulky instrumentation in centralized laboratories and an assay time of 1–2 h. Here, we show that SARS-CoV-2 RNA can be detected in 17 min via a portable device integrating reverse transcription, fast thermocycling (via plasmonic heating through magneto-plasmonic nanoparticles) and in situ fluorescence detection following magnetic clearance of the nanoparticles. The device correctly classified all nasopharyngeal, oropharyngeal and sputum samples from 75 patients with COVID-19 and 75 healthy controls, with good concordance in fluorescence intensity with standard RT–qPCR (Pearson coefficients &gt; 0.7 for the <italic>N1</italic>, <italic>N2</italic> and <italic>RPP30</italic> genes). Fast, portable and automated nucleic acid detection should facilitate testing at the point of care.</p></abstract><abstract xml:lang="en" id="Abs2" abstract-type="ShortSummary"><p id="Par2">A portable device integrating reverse transcription, fast thermocycling and in situ fluorescence detection accurately detects SARS-CoV-2 RNA in patient samples in 17 min.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>Institute for Basic Science (IBS)</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">https://doi.org/10.13039/501100010446</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant">IBS-R026-D1</award-id><principal-award-recipient><name><surname>Cheon</surname><given-names>Jinwoo</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>Nature Research</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>12</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>15</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2020</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s), under exclusive licence to Springer Nature Limited</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2020</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>Yes</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2020</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>11</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>2</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>NonStandardArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/41551_2020_Article_654.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-year</meta-name><meta-value>2020</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-month</meta-name><meta-value>12</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-day</meta-name><meta-value>8</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Biomedicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Biomedicine, general</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Biomedical Engineering/Biotechnology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Biomedical and Life Sciences</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>false</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="CrossLinking"><sec><p>A correction to this article is available online at <ext-link xlink:href="10.1038/s41551-020-00676-8" ext-link-type="doi">https://doi.org/10.1038/s41551-020-00676-8</ext-link>.</p></sec></notes></front><body><sec id="Sec1"><title>Main</title><p id="Par3">Developing fast and reliable diagnostic tools is critical during the current coronavirus disease 2019 (COVID-19) pandemic, as diagnostic capacity at scale becomes critical to containing outbreaks and to reducing fatality rates<sup><xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR7">7</xref></sup>. In the absence of effective cures or vaccines for the disease, identifying as many infected individuals as possible (both symptomatic and asymptomatic) and then isolating them is the most effective way to prevent disease transmission<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. Administering on-site and rapid tests is ideal for prompt patient triaging and contact tracing. Unfortunately, diagnostic tools with such capabilities are not readily available. Immunogenic lateral-flow assays are fast, small and cost effective, but are unsuitable for viral detection during the early disease phase<sup><xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref></sup>. Nucleic acid amplification tests based on PCR are the gold standard for COVID-19 confirmation, owing to their high analytical accuracy (~99%)<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. A caveat, however, is that most PCR tests are carried out in centralized laboratories, which often incur logistic overheads (such as sample transfer and protection from degradation) and long turnaround times (2–3 d)<sup><xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref></sup>. The deployment of conventional PCR to point-of-care (POC) settings is also limited by lengthy assay times (~1–2 h) and the need for bulky instrumentation. New isothermal nucleic acid amplification technologies may shorten assay times, but they are less established than conventional PCR (because of supply chain issues and the need for clinical validation) and may have inferior accuracy<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>.</p><p id="Par4">Rapid and portable thermocycling technology aims to bring nucleic acid amplification tests to POC settings. Thermoplasmonics is a promising method for fast heating<sup><xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR25">25</xref></sup>. It exploits the light-to-heat conversion mediated by plasmonic substrates<sup><xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR29">29</xref></sup>. This concept has been adopted for PCR thermocycling, in the form of a planar plasmonic substrate in a fluidic device<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup> or metallic nanoparticles in suspension<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. Both methods have shown fast nucleic acid amplification, but challenges remain: nucleic acids after amplification are difficult to detect because plasmonic substrates would interfere with fluorescence reporters<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. Improving the detection sensitivity often entails additional steps involving the use of external equipment (in particular, centrifugation (for particle removal), gel electrophoresis (for separate signal detection) or a microscope system) (Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">1</xref>). These requirements would lengthen the total assay time, overshadowing the advantage of fast thermocycling, and would also complicate the workflow.</p><p id="Par5">Here, we report the development of a fast one-pot PCR with reverse transcription (RT–PCR) technology for COVID-19 diagnostics. We named it nanoPCR. The system seamlessly integrates plasmonic thermocycling with fluorescent signal detection in a single device. A key concept is the use of dual-functional magneto-plasmonic nanoparticles (MPNs) for PCR applications. We noticed that most of the plasmonic effect is confined near the surface of plasmonic nanoparticles. By encasing a magnetic core with a plasmonic gold (Au) shell, we could thus achieve: (1) efficient plasmonic heating comparable to that by solid Au nanoparticles; and (2) rapid nanoparticle separation with external magnetic fields to perform in situ signal detection. Exploiting these advantages, we advanced a compact nanoPCR system that automatically executes reverse transcription, rapid PCR amplification and fluorescence detection with a single button press. The current prototype concurrently measures three samples within 17 min. The limit of detection is 3.2 gene copies per µl, which is comparable to those by benchtop PCR equipment. We further applied nanoPCR to test clinical samples (75 patients with COVID-19 and 75 controls). The nanoPCR device rapidly detected three gene targets (<italic>N1</italic>, <italic>N2</italic> and <italic>RPP30</italic>) and achieved excellent diagnostic accuracy (&gt;99%).</p></sec><sec id="Sec2" sec-type="results"><title>Results and discussion</title><p id="Par6">We used nucleic acid targets recommended by the US Center for Disease Control and Prevention (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>)<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>: <italic>N1</italic> and <italic>N2</italic> genes (for severe acute respiratory syndrome 2 (SARS-CoV-2) virus detection) and the human <italic>RPP30</italic> gene (for human sample confirmation). Figure <xref rid="Fig1" ref-type="fig">1b</xref> shows the nanoPCR schematic for 17-min COVID-19 diagnostics (see Supplementary Video <xref ref-type="supplementary-material" rid="MOESM3">1</xref> for the whole workflow). The assay starts with extracting total RNAs from suspected patient samples (for example, nasopharyngeal/oropharyngeal swabs or sputum). Extracted RNA samples are then mounted inside a nanoPCR device, and the remaining assay steps are carried out automatically: (1) thermoplasmonic RT–PCR (11 min); (2) magnetic fluorescence switch (MFS) to remove MPNs from samples using an external magnetic field (3 min); and (3) fluorescence signal detection directly from tubes (&lt;20 s). Overall, the nanoPCR offers practical advantages for on-site molecular diagnostics. The dual-functional MPNs enable both rapid nucleic acid amplification (via plasmonic heating) and the detection of fluorescent signal (via MPN clearing) in a one-pot assay format.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><title>NanoPCR assay schematics for COVID-19 diagnostics.</title><p><bold>a</bold>, Target RNA regions for nanoPCR tests. The <italic>N1</italic> and <italic>N2</italic> genes are for SARS-CoV-2 detection, whereas the <italic>RPP30</italic> gene serves as a control for human sample confirmation. ORF, open reading frame; S, spike; E, envelope; M, membrane; N, nucleocapsid. <bold>b</bold>, High-speed nanoPCR diagnostic flow for SARS-CoV-2 detection: (1) 3 min of RNA extraction using a disposable RNA preparation kit; (2) 11 min of RT–PCR by magneto-plasmonic thermocycling; and (3) 3 min of detection and diagnosis via MFS by application of an external magnetic field for MPN removal. <bold>c</bold>, A disposable RNA extraction kit with preloaded buffers and a simple plunge system. <bold>d</bold>, A compact nanoPCR instrument for POC application. The system houses a light source for plasmonic heating, a Ferris wheel for sample mounting, MFS magnets and optics for fluorescence detection. <bold>e</bold>, Circular array of the low-powered laser diodes and synchronized Ferris wheel for thermocycling of multiple samples. <bold>f</bold>, Syncing of laser illumination with Ferris wheel rotation to enable the processing of multiple samples without compromising the total assay time.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41551_2020_654_Fig1_HTML.png"/></fig></p><p id="Par7">To facilitate sample preparation at POC settings, we designed a disposable RNA preparation kit (Fig. <xref rid="Fig1" ref-type="fig">1c</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1</xref>). The kit has multiple chambers preloaded with RNA extraction reagents (see Methods for details) and a silica filter to capture RNA (that is, solid-phase extraction). After loading a test sample (20 µl), we sequentially actuated plungers to perform virus lysis, RNA capture and elution to PCR tubes. When tested with human coronavirus NL63, the kit achieved extraction yields comparable to those achieved by a conventional centrifugation method (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">2</xref>); however, the kit operation was equipment free and complete within 3 min.</p><p id="Par8">We implemented a compact nanoPCR system, integrating key components for plasmonic RT–PCR. Specifically, the system had a light source for plasmonic heating, a rotating sample holder (Ferris wheel style), movable magnets and a fluorescent optical setup (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>). A microcontroller coordinated the operation of individual modules: with a single button push, the system automatically executed plasmonic RT–PCR, MFS and fluorescence detection and displayed the results on an embedded screen (Supplementary Video <xref ref-type="supplementary-material" rid="MOESM3">1</xref>). This self-contained system had a small form factor (15 × 15 × 18.5 cm<sup>3</sup>) and weighed ~3 kg (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>).</p><p id="Par9">As the plasmonic light source, we arranged weak-powered (80 mW) laser diodes in a circular array (Fig. <xref rid="Fig1" ref-type="fig">1e</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">3</xref>), which allowed for more even illumination on samples than using a single high-power (~1 W) laser. For the sample mounting, we adopted a Ferris wheel scheme to achieve higher throughput. The wheel rotation sequentially brought a sample under light illumination while other samples were air cooled. By syncing the wheel rotation and the illumination schedule (Fig. <xref rid="Fig1" ref-type="fig">1f</xref>), we could perform PCR reactions in multiple samples using an existing light source. The method thereby provided an economical way to scale up (see Supplementary Note <xref ref-type="supplementary-material" rid="MOESM1">2</xref> for details). The current POC prototype was designed for three samples. We also constructed a prototype that could process nine samples (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">4</xref>), which had the throughput of processing roughly 36 samples per hour.</p><p id="Par10">The essential nanoPCR reagent was the dual-functional MPNs for plasmonic heating and magnetic clearing. The particle had a 16-nm magnetic core (Zn<sub>0.4</sub>Fe<sub>2.6</sub>O<sub>4</sub>) enclosed by a 12-nm-thick Au shell (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>, left)<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Elemental mapping with energy dispersive X-ray spectroscopy (EDS) confirmed the MPNs’ core–shell nature (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>, right). We further coated the particles with phosphine–sulfonate ligands, which stabilized MPNs by imparting negative surface charges. The hydrodynamic size of MPNs measured with dynamic light scattering (DLS) was ~50 nm without aggregation and they maintained excellent colloidal stability for 1 year without a change in size (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">5</xref>).<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><title>MPNs.</title><p><bold>a</bold>, TEM images of MPNs with a core–shell (Zn<sub>0.4</sub>Fe<sub>2.6</sub>O<sub>4</sub>-Au) structure. Left: a 16-nm magnetic core was encased by a 12-nm Au shell. Right: elemental mapping of Au and Fe showed an area-specific distribution of the core and Au shell structure. <bold>b</bold>, Ultraviolet–visible cross-section absorption spectrum of an MPN measured with the integrating sphere. At a shell thickness of 12 nm, the highest absorbance was measured at 535 nm. <bold>c</bold>, Simulation of the electric field at 535 nm illumination. An intense electric field was confined to the Au surface. <bold>d</bold>, Linear profile of the maximum electric field enhancement factor (<italic>E</italic>/<italic>E</italic><sub>0</sub>) (dotted line in <bold>c</bold>). <bold>e</bold>, Estimated magnetization curve of a single MPN, as measured using a vibrating sample magnetometer. MPNs are superparamagnetic at room temperature (20 °C). <bold>f</bold>, The clustered form of MPN was realized by dipolar interaction under magnetic field application (100 T m<sup>−1</sup>). <bold>g</bold>, Hydrodynamic sizes of MPNs before and after clustering, as measured by DLS. The size increased from 50 to 530 nm.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41551_2020_654_Fig2_HTML.png"/></fig></p><p id="Par11">We characterized the MPNs’ optical properties, measuring plasmonic responses and simulating electric fields. With the 12-nm-thick Au shell, the MPNs showed plasmon resonance at a wavelength (<italic>λ</italic>) of 535 nm, which matched with the peak wavelength (532 nm) of the laser diode used in the system (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). The electric field map under plasmonic resonance, simulated by the boundary element method (see Methods), indicated that the field enhancement was particularly confined to both the inner and outer surfaces of the Au shell (Fig. <xref rid="Fig2" ref-type="fig">2c,d</xref>). In addition, the electric field enhancement (<italic>E</italic>/<italic>E</italic><sub>0</sub>) and cross-section absorption (<italic>σ</italic><sub>abs</sub>) of a single MPN were similar to those of a solid 40-nm Au nanoparticle (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">6</xref>). These results supported that the core–shell structure could maintain the desired surface plasmonic properties while providing additional functionality through the core.</p><p id="Par12">Magnetic measurements confirmed that the MPNs were superparamagnetic, with a magnetic moment of <italic>m</italic> = 7.52 × 10<sup>−19</sup> A m<sup>2</sup> per particle (Fig. <xref rid="Fig2" ref-type="fig">2e</xref>). Under the magnetic field generated by an external NdFeB magnet, MPNs clustered through dipole–dipole interactions, which increased the overall hydrodynamic size (from 50 to 530 nm) (Fig. <xref rid="Fig2" ref-type="fig">2f,g</xref>). The magnetic moment of clustered MPNs was estimated to be much higher (8.96 × 10<sup>−16</sup> A m<sup>2</sup>)—approximately 1,200 times higher than a single MPN (see Supplementary Note <xref ref-type="supplementary-material" rid="MOESM1">1</xref>). This feature enabled us to quickly clear MPNs from solution, facilitating the interference-free fluorescent detection.</p><p id="Par13">We used MPNs as a volumetric heating source in the plasmonic RT–PCR. Shining light on the MPN-containing solution quickly heated the entire sample (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). The heating effect was dominant only when the incident wavelength matched to the MPNs’ plasmonic resonance (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>), confirming the underlying thermoplasmonic mechanism. We further developed an analytical model to estimate the temperature increase in the MPN solution. Approximating a single MPN as a spherical heater, the temperature profile around the particle is given as ∆<italic>T</italic><sub>MPN</sub> = (<italic>σ</italic><sub>abs</sub><italic>I</italic>)/(4π<italic>R</italic><italic>k</italic><sub>s</sub>), where <italic>k</italic><sub>s</sub> is the thermal conductivity of the solution, <italic>I</italic> is the irradiance of the illumination and <italic>R</italic> is the particle radius<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Under our experimental conditions (<italic>σ</italic><sub>abs</sub> = 2.5 × 10<sup>3</sup> nm<sup>2</sup>, <italic>R</italic> = 20 nm, <italic>k</italic><sub>s</sub> = 0.6 W m<sup>−1</sup> K<sup>−1</sup> for water and <italic>I</italic> = ~0.1 W mm<sup>−</sup><sup>2</sup>), the overall temperature increase of the solution is estimated as ∆<italic>T</italic> = ∆<italic>T</italic><sub>MPN</sub>(<italic>R</italic>/<italic>δ</italic>)<italic>N</italic><sup>2/3</sup>, where <italic>N</italic> is the total number of MPNs and <italic>δ</italic> is the inter-particle distance<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. With <italic>N</italic> particles suspended in volume <italic>V</italic>, <italic>δ</italic> = ~0.55(<italic>V</italic>/<italic>N</italic>)<sup>1/3</sup>, leading to ∆<italic>T</italic> = 2∆<italic>T</italic><sub>MPN</sub>(<italic>N</italic>/<italic>V</italic>)<italic>V</italic><sup>2/3</sup>. Therefore, a linear increase in ∆<italic>T</italic> with MPN concentration ([MPN]) is expected (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>, dotted lines), which agrees well with the experimental observations (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>, circles). The heating efficiency, however, deteriorated when [MPN] ≳ 3 × 10<sup>11</sup> ml<sup>−1</sup>; this could be attributed to shifts in plasmonic resonance caused by inter-particle coupling<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. To maximize the heating efficiency, we set [MPN] = 2.6 × 10<sup>11</sup> ml<sup>−1</sup> for the rest of the assay.<fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><title>MPN-induced plasmonic heating.</title><p><bold>a</bold>, Thermal images of plasmonically heated MPN solution (light source = 1,000 mW at <italic>λ</italic> = 532 nm; solution volume = 10 µl; MPN concentration = 2.6 × 10<sup>11</sup> particles per ml). The solution temperature changed from 25 to 90 °C within a few seconds upon laser illumination. <bold>b</bold>, Temperature profile of MPN solutions with different wavelengths of light illumination. The laser diode with a wavelength of 532 nm matched closely to the maximum absorption of MPN; thereby, faster heating was induced. <bold>c</bold>, Effect of MPN concentration on the temperature profile (dotted line: theoretical estimation; circle: measured values). The maximum temperature increase was observed at a concentration of 2.6 × 10<sup>11</sup> particles per ml. At higher concentrations, the heating effect degenerated. <bold>d</bold>, High-speed plasmonic thermocycling profile of MPN solution (seven cycles per min; 58–90 °C). <bold>e</bold>, Single thermocycling of MPN solution (red dotted rectangle in <bold>d</bold>). The heating rate was 13.17 °C s<sup>−1</sup> and the cooling rate was 4.94 °C s<sup>−1</sup>. The temperature deviations (right) were from five cycles at 58 (blue) and 90 °C (red). Data are mean ± s.e.m. The values were &lt;1% compared with the target temperature. <bold>f</bold>, Schematic of the synchronized Ferris wheel system for multi-sample thermocycling. Sample rotation and laser illumination were synced to heat three samples. <bold>g</bold>, Temperature profiles of three samples on the wheel. Individual heating profiles were interleaved such that the total cycling time remained the same.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41551_2020_654_Fig3_HTML.png"/></fig></p><p id="Par14">Applying MPN plasmonic heating, we could achieve rapid thermocycling (58 to 90 to 58 °C) at a rate of 8.91 s per cycle (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>). The precision at target temperatures was excellent, with the coefficient of variations &lt;1.64% (Fig. <xref rid="Fig3" ref-type="fig">3e</xref>). Note that we relied on the convective heat transfer to air for the sample cooling. The observed cooling time from 90 to 58 °C was ~6.5 s, which also agreed with the numerical modelling (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">7</xref>). Such fast cooling was possible mainly because the sample volume was small (10 µl). For COVID-19 detection, we tuned the Ferris wheel for three-sample measurement (Fig. <xref rid="Fig3" ref-type="fig">3f</xref>), with each sample targeting one of three genes for COVID-19 diagnostics (that is, <italic>N1</italic>, <italic>N2</italic> and <italic>RPP30</italic>). By synching the wheel rotation with the heating cycle (2.43 s under light; 6.48 s with air cooling), we could continuously process three samples using a light source designed for a single PCR tube (Fig. <xref rid="Fig3" ref-type="fig">3g</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">8</xref>).</p><p id="Par15">Next, we optimized the entire operation for SARS-CoV-2 gene detection (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). The process required maintaining a constant temperature for reverse transcription. We controlled the effective light power by modulating the on/off duty cycle, achieving the target temperature (42 °C) with small variations (&lt;1 °C; Fig. <xref rid="Fig4" ref-type="fig">4a</xref> right). Testing with <italic>N1</italic>, <italic>N2</italic> and <italic>RPP30</italic> target genes, we confirmed that the 5-min reverse transcription produced sufficient numbers of complementary DNAs (see Methods and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">9</xref>). Following the reverse transcription reaction, we executed the PCR amplification (40 cycles per tube; 6 min). Gel electrophoresis on PCR products by nanoPCR (6 min) and by conventional benchtop instrument (2 h) showed matching bands (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>), confirming comparable performance between two systems. With 5-min conventional PCR, no band was detected (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">10</xref>). We further assessed the purity of the PCR products by measuring ultraviolet absorbance ratios (<italic>A</italic><sub>260</sub>/<italic>A</italic><sub>230</sub> and <italic>A</italic><sub>260</sub>/<italic>A</italic><sub>280</sub>), where <italic>A</italic><sub>230</sub>, <italic>A</italic><sub>260</sub> and <italic>A</italic><sub>280</sub> are the ultraviolet absorbance at 230, 260 and 280 nm, respectively (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">11</xref>). The measured ratios were <italic>A</italic><sub>260</sub>/<italic>A</italic><sub>230</sub> = ~2.2 and <italic>A</italic><sub>260</sub>/<italic>A</italic><sub>280</sub> = ~1.8. <italic>A</italic><sub>260</sub>/<italic>A</italic><sub>230</sub> was higher than <italic>A</italic><sub>260</sub>/<italic>A</italic><sub>280</sub>, indicating that nanoPCR produced high-quality PCR products.<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><title>NanoPCR detection of SARS-CoV-2 genes.</title><p><bold>a</bold>, Measured temperature profiles of a sample under nanoPCR. Left: 42 °C incubation for reverse transcription (5 min), followed by PCR amplification (40 cycles; 6 min), then signal detection steps (3 min). The whole RT–PCR process was complete within 11 min. Right: enlarged temperature profile during the isothermal reverse transcription phase. <bold>b</bold>, Gel electrophoresis images of PCR products from the 11-min nanoPCR and a 2-h conventional benchtop thermocycler, for <italic>N1</italic>, <italic>N2</italic> and <italic>RPP30</italic> genes. All of the bands were detected identically for both methods. NTC, non-target control. <bold>c</bold>, MFS for in situ detection of amplicons. Brightfield (BF) and fluorescence (FL) photographs of an assay mixture before and after 3 min of MFS application are shown. <bold>d</bold>, <italic>N1</italic> gene fluorescence signal changes during MFS application (<italic>n</italic> = 3). 50% signal recovery was achieved at 3 min. <bold>e</bold>, Detection of <italic>N1</italic>, <italic>N2</italic> and <italic>RPP30</italic> genes before (−) and after (+) MFS application (<italic>n</italic> = 5 for each measurement). <bold>f</bold>, Evaluation of the LOD of nanoPCR with different amounts of target <italic>N1</italic> RNA (<italic>n</italic> = 3). The detection threshold was set at three times the standard deviation of the signal from a blank. The LOD (dashed horizontal line) was 3.2 copies of gene per μl. <bold>g</bold>, Specificity evaluation for different strains of coronavirus (that is, <italic>N1</italic> and <italic>N2</italic> genes from SARS-CoV-2, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV)) (<italic>n</italic> = 3 for each measurement). Data in <bold>d</bold>–<bold>g</bold> are mean ± s.d.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41551_2020_654_Fig4_HTML.png"/></fig></p><p id="Par16">For fluorescence signal detection in situ, we applied MFS to clear MPNs in sample tubes. After completing the RT–PCR reaction, the nanoPCR system automatically moved a magnet array to the Ferris wheel (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>, left; see Supplementary Video <xref ref-type="supplementary-material" rid="MOESM3">1</xref>) and read out the fluorescence signal using an internal ultraviolet light-emitting diode (LED) and a photodiode (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">12</xref>). Under the field gradient (100 T m<sup>−1</sup>) created by the magnet, MPNs clustered and sedimented to the tube bottom (see Supplementary Note <xref ref-type="supplementary-material" rid="MOESM1">1</xref>). We observed that MFS was indispensable for reliable measurements. Without MFS, amplicons’ signal from fluorescein amidites (FAMs) was barely detectable (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>, right), presumably due to the spectral overlap between MPN absorption (<italic>λ</italic><sub>peak</sub> = 535 nm) and FAM emission (<italic>λ</italic><sub>em</sub> = 517 nm). When tested with <italic>N1</italic> amplicons, the fluorescence signal recovered to ~50% of its saturation level at 3 min after MFS (Fig. <xref rid="Fig4" ref-type="fig">4d</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">13</xref>). Applying this timing, we could reliably detect all three target genes (<italic>N1</italic>, <italic>N2</italic> and <italic>RPP30</italic>; Fig. <xref rid="Fig4" ref-type="fig">4e</xref>). Of note, nanoPCR is inherently limited to end-point measurements, as the assay detects signal only after PCR reaction.</p><p id="Par17">With operational parameters determined, we evaluated the analytical performance of nanoPCR, benchmarking it against conventional RT–PCR. To estimate the limit of detection (LOD), serially diluted samples containing <italic>N1</italic>, <italic>N2</italic> or <italic>RPP30</italic> target genes were prepared and subjected to the complete nanoPCR procedures (that is, reverse transcription, 40-cycle PCR and MFS). The LOD was calculated to be 3.2 copies per µl based on the standard formula (threshold = 3 × s.d. of a blank sample; Fig. <xref rid="Fig4" ref-type="fig">4f</xref>), which was comparable to that of conventional RT–PCR (2.0 copies per µl)<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>. Furthermore, nanoPCR-based <italic>N1</italic> and <italic>N2</italic> detection distinguished SARS-CoV-2 from other zoonotic coronaviruses, SARS-CoV and Middle East respiratory syndrome coronavirus, with negligible cross-reactivity (Fig. <xref rid="Fig4" ref-type="fig">4g</xref>).</p><p id="Par18">To validate nanoPCR’s clinical applicability, we tested clinical samples (that is, nasopharyngeal/oropharyngeal swabs and sputum samples) from cohorts of patients with COVID-19 and control individuals without COVID-19 (see Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">2</xref> for patient information). COVID-19 infection status was independently confirmed by the Clinical Diagnostic Laboratory at Chonnam National University Hospital (Republic of Korea). We used the first 100 samples as a discovery cohort (50 patients with COVID-19 and 50 controls) and another 50 samples (25 patients with COVID-19 and 25 controls) as a validation cohort (Fig. <xref rid="Fig5" ref-type="fig">5a</xref>). Each patient sample was divided into two. One aliquot was processed using the nanoPCR and the other using a benchtop PCR system. Both assays used the same <italic>N1</italic>, <italic>N2</italic> and <italic>RPP30</italic> probes. As a positive reference, we also processed a control sample containing a known amount of reference RNA (synthetic <italic>N1</italic> RNA).<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><title>Testing of clinical samples with nanoPCR for COVID-19 diagnosis.</title><p><bold>a</bold>, Clinical study design. A total of 150 samples were analysed by nanoPCR and conventional RT–PCR. The first 100 samples were used as a discovery cohort and the remaining 50 were used as a validation cohort. <bold>b</bold>, Evaluation of analytical concordance between nanoPCR and RT–qPCR. The results were positively correlated (Pearson’s <italic>r</italic> values; <italic>r</italic><sub><italic>N1</italic></sub> = 0.87; <italic>r</italic><sub><italic>N2</italic></sub> = 0.78; <italic>r</italic><sub><italic>RPP30</italic></sub> = 0.70). The limit of quantification of both RT–qPCR and nanoPCR was plotted on each axis (broken lines parallel to the axes). Raw intensities from nanoPCR were used. <bold>c</bold>–<bold>e</bold>, Analysis of the discovery cohort. <bold>c</bold>, Control-normalized <italic>N1</italic> and <italic>N2</italic> signal levels (<italic>F</italic><sub><italic>N1</italic></sub> and <italic>F</italic><sub><italic>N2</italic></sub>) for 50 patients with COVID-19 and 50 controls. <bold>d</bold>, <italic>F</italic> values were significantly higher in the patients with COVID-19 (+) than in controls (−) (****<italic>P</italic> &lt; 0.0001; two-sided <italic>t</italic>-test; <italic>n</italic> = 100). <bold>e</bold>, ROC curves. The AUC was 1 for both <italic>N1</italic> and <italic>N2</italic>. The <italic>F</italic> cut-off values for diagnostics were determined from the ROC curves: 0.15 (<italic>F</italic><sub><italic>N1</italic></sub>) and 0.05 (<italic>F</italic><sub><italic>N2</italic></sub>). <bold>f</bold>, The diagnostic accuracy was further confirmed with the validation cohort (<italic>n</italic> = 50). Cut-offs (dotted lines) from the discovery set were applied. As in <bold>d</bold>, <italic>F</italic> values were significantly higher in the patients with COVID-19 (+) than in controls (−) (****<italic>P</italic> &lt; 0.0001; two-sided <italic>t</italic>-test). <bold>g</bold>, Waterfall distribution of F<sub><italic>N1</italic></sub> and F<sub><italic>N2</italic></sub> for all of the samples tested (<italic>n</italic> = 150).</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41551_2020_654_Fig5_HTML.png"/></fig></p><p id="Par19">Figure <xref rid="Fig5" ref-type="fig">5b</xref> shows the results from nanoPCR and quantitative PCR with reverse transcription (RT–qPCR). We compared raw fluorescence intensity <italic>I</italic>(nanoPCR) with <italic>–</italic>log<sub>2</sub>[Ct], where Ct is the cycle cut-off of RT–qPCR; these two quantities would be proportional to target gene concentrations. We observed a good concordance between these two methods. For each gene target, nanoPCR and RT–qPCR showed a strong positive correlation with the Pearson coefficient (<italic>r</italic>) values of 0.87 (<italic>N1</italic>), 0.78 (<italic>N2</italic>) and 0.70 (<italic>RPP30</italic>).</p><p id="Par20">Next, we assessed the diagnostic accuracy of nanoPCR. As system-independent analytical measures, we defined <italic>F</italic><sub><italic>N1</italic></sub> and <italic>F</italic><sub><italic>N2</italic></sub> by normalizing the fluorescence intensities of the target genes (<italic>N1</italic> and <italic>N2</italic>) with that of the positive reference (Fig. <xref rid="Fig5" ref-type="fig">5c</xref>). The <italic>F</italic><sub><italic>N1</italic></sub> and <italic>F</italic><sub><italic>N2</italic></sub> values were significantly higher (<italic>P</italic> &lt; 0.0001 for both; two-sided <italic>t</italic>-test) in patients with COVID-19 than in controls (Fig. <xref rid="Fig5" ref-type="fig">5d</xref>). We further constructed receiver operating characteristic (ROC) curves for <italic>F</italic><sub><italic>N1</italic></sub> and <italic>F</italic><sub><italic>N2</italic></sub>. The diagnostic accuracy was excellent, with an area under the curve of 1 (Fig. 5e) for both <italic>F</italic><sub><italic>N1</italic></sub> and <italic>F</italic><sub><italic>N2</italic></sub>. From ROC curves, we determined optimal cut-offs, <italic>F</italic><sub><italic>TH_N1</italic></sub> = 0.15 for <italic>F</italic><sub><italic>N1</italic></sub> and <italic>F</italic><sub><italic>TH_N2</italic></sub> = 0.05 for <italic>F</italic><sub><italic>N2</italic></sub>, that maximized the sum of sensitivity and specificity. When these cut-offs were applied to a separate validation set (25 patients with COVID-19 and 25 controls), nanoPCR maintained its high diagnostic power (Fig. <xref rid="Fig5" ref-type="fig">5f</xref>). Overall, rapid nanoPCR diagnostics correctly classified all of the clinical samples (<italic>n</italic> = 150) tested (Fig. <xref rid="Fig5" ref-type="fig">5g</xref> and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">14</xref>).</p><p id="Par21">Overall, nanoPCR has the potential to decentralize COVID-19 molecular diagnosis. It has practical advantages: (1) the assay is based on well-established RT–PCR to produce more reliable and accurate (&gt;99%) results than isothermal amplification tests<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>; and (2) nanoPCR considerably shortens the PCR reaction time to enable on-site diagnostics. With these advantages, nanoPCR could contribute to the decentralization of COVID-19 tests into mobile, ambulatory clinics, mitigating the logistic burden of sample transports. Our prototype system demonstrated such potential, meeting some of the criteria (for example, a sensitivity of &gt;80%, a specificity of &gt;97% and an assay time of &lt;40 min) set by the World Healthcare Organization<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. Also, MPN synthesis can be optimized for mass production where a single batch currently provides ~30,000 PCR reactions (~50 mg). For nanoPCR to be used in clinical settings, we envision further technical developments: (1) establishing MPN quality control and good manufacturing practice for mass production; (2) redesigning fluidic cartridges to minimize hands-on times in RNA extraction<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>; and (3) exploring new assay methods, such as heat-inactivated lysis<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, to offer sample-in and answer-out tests. These efforts will expand nanoPCR’s utility in remote or resource-limited settings<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. NanoPCR could also be applied for the prompt diagnosis of other infections, such as acquired immunodeficiency syndrome, tuberculosis and hepatitis<sup><xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR50">50</xref></sup>.</p></sec><sec id="Sec3" sec-type="methods"><title>Methods</title><sec id="Sec4"><title>Synthesis of MPNs</title><p id="Par22">The MPNs were synthesized as previously described<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Briefly, the magnetic core (M) was synthesized by nonhydrolytic thermal decomposition of Fe(<sc>iii</sc>) acetylacetonate and zinc chloride in oleic acid, oleylamine and trioctylamine at 330 °C. After washing the products with ethanol, 1 mg silica-coated magnetic core with an amine functional group (M@SiO<sub>2</sub>-NH<sub>2</sub>) was prepared by the sol-gel process of tetraethylorthosilicate and aminopropyltrimethoxysilane. The 2-nm colloidal Au nanoseeds were mixed with M@SiO<sub>2</sub>-NH<sub>2</sub> to obtain an Au seed-coated magnetic core (M@Au = 2 nm) at room temperature for 5 h. To prepare the complete Au shell, the Au seeds were grown in 4.8 l of titrated Au precursors with 17.2 mg hydroxylamine hydrochloride (NH<sub>2</sub>OH) for 3 d. After separation with centrifugation and a magnetic column, typically the yield was higher than 65%, corresponding to 150 pmoles (~50 mg). The products were dispersed in 1 mg ml<sup>−1</sup> bis(<italic>p</italic>-sulfonatophenyl)phenylphosphine dehydrate dipotassium salt solution for long-term storage.</p></sec><sec id="Sec5"><title>Transmission electron microscopy (TEM) analysis and EDS mapping</title><p id="Par23">TEM observations were made using an Atomic Resolution Analytical Electron Microscope (JEM-ARM200F; JEOL) at an acceleration voltage of 200 kV. MPNs were freshly prepared on a plasma-cleaned TEM grid (Ultra-Thin PELCO Grids for TEM; Ted Pella). Elemental analysis derived from EDS was performed under atomic resolution mapping followed by visualized indexing.</p></sec><sec id="Sec6"><title>Plasmonic simulation of MPNs</title><p id="Par24">Electrical fields of MPNs and Au nanoparticles were simulated using the MNPBEM Toolbox in MATLAB (MathWorks)<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. The toolbox adopted the boundary element method approach<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>, solving Maxwell’s equations in metallic nanoparticles wherein homogeneous and isotropic dielectric functions are separated by abrupt interfaces. The simulation assumed that a particle was immersed in water. Wavelength-dependent dielectric functions for Au and magnetite were used.</p></sec><sec id="Sec7"><title>Spectral analysis of MPNs</title><p id="Par25">Diluted down to an optical density of 0.1 at <italic>λ</italic> = 535 nm, the aqueous solution of MPNs was subjected to ultraviolet light-aligned spectral analysis using an ultraviolet–visible spectrometer (V-760; Jasco) for absorbance analysis. To obtain scattering measurements for coefficient calculation, the solution was transferred into the integrating sphere (Quanta-phi; HORIBA Scientific) and analysed by photoluminescence spectroscopy (HORIBA Scientific).</p></sec><sec id="Sec8"><title>Vibrating sample magnetometer measurements</title><p id="Par26">An aqueous solution of MPNs was subject to measurement of magnetization using a vibrating sample magnetometer (VIBRATION 7407-S; Lake Shore Cryotronics). For mass magnetization, the mass of Fe, Zn and Au of each sample was determined using inductively coupled plasma mass spectrometry (7900 ICP-MS; Agilent Technologies).</p></sec><sec id="Sec9"><title>DLS measurements</title><p id="Par27">The hydrodynamic size of MPNs was measured using a DLS device (Nano ZS90; Malvern) with the following parameters: refractive index = 0.21 and absorption = 3.32.</p></sec><sec id="Sec10"><title>Preparation of nanoPCR mix</title><p id="Par28">NanoPCR mix (total volume = 10 μl) consisting of 0.2 μM specific primers (Bioneer; see Supplementary Table <xref ref-type="supplementary-material" rid="MOESM1">3</xref>), 20 μM oligo dT, MPNs at an optical density of 4, 200 μM dNTPs (N0447S; New England Biolabs), 10 μM dithiothreitol, 2% dimethyl sulfoxide, 0.22 μM specific TaqMan probe (Integrated DNA Technologies) (or 1× SYBR Safe (Invitrogen) in the non-clinical study), 0.5 μl RNase Inhibitor (LS63; NIPPON Genetics EUROPE), 1 U FastGene Scriptase II (LS63-2; NIPPON Genetics EUROPE), 1 U Hot Start Taq DNA Polymerase (M0495; New England Biolabs), 0.4× Standard Taq Reaction Buffer (containing 10 mM Tris-HCl, 50 mM KCl and 1.5 mM MgCl<sub>2</sub> (pH 8.3) at 1× concentration; New England Biolabs) and 0.2× Reverse Transcription Buffer (containing 10 mM Tris-HCl, 50 mM KCl and 0.1% Triton X-100 at 1× concentration (LS63; NIPPON Genetics EUROPE)) was prepared. A certain concentration of synthetic target RNA or viral RNA of clinical samples was applied to the mix, which was then subjected to RT–PCR in the nanoPCR device to automatically give a fluorescence result for the sample.</p></sec><sec id="Sec11"><title>RNA preparation kit</title><p id="Par29">We engineered a customized RNA-processing kit (20 × 68 × 83 mm<sup>3</sup>) using a three-dimensional (3D) printer (Form 3; Formlabs). Viral RNAs from collected biofluid samples could be purified via the kit’s silica gel membrane, where RNAs were bound, washed and eluted. Five individual chambers were used, one at a time, to purify the RNAs. The operational procedure of the kit was as follows: (1) transfer of the sample (20 µl) mixed with RNA shield (20 µl) onto the top of the membrane (15 s); (2) application of viral RNA buffer (400 µl guanidinium thiocyanate and acid phenol) for capsid degradation (15 s); (3) pre-washing and RNA immobilization with ion-exchange chromatography resin (1 ml; 2 min); (4) application of viral wash buffer (500 µl; containing ethanol) for debris washing (30 s); and (5) application of elution buffer (15 µl) and transfer to a tube preloaded with the customized nanoPCR reagents and primers (10 s). All of the reagents and buffers were from a commercial RNA extraction kit (R1034; Zymo Research) and were preloaded into the corresponding chambers before RNA processing. Due to the manufacturing shortcoming for mass production, the disposable RNA preparation kit was used sparingly (<italic>n</italic> = 5) with the sole aim of confirming its capability.</p></sec><sec id="Sec12"><title>POC device configuration</title><p id="Par30">A 3D-printed plastic housing (150 × 150 × 185 mm<sup>3</sup>) contained optoelectronic components and served as a dark chamber to exclude external light during the RT–PCR and fluorescence measurements. Three sample tubes (PCR-02-C; Corning) were installed separately onto the customized synchronized Ferris wheel. An array of 14 532-nm lasers (CK1872; CivilLaser) was installed for plasmonic heating, and a 310-nm ultraviolet LED (LED310W; Thorlabs) was added for fluorescence excitation. The tubes formed a trigonal planar arrangement to make an organized rotation with exact timing, and the bottom solution region of the tube in the reaction order was focused by the lasers (RT–PCR) or the ultraviolet LED (fluorescence detection). The lasers were arranged in a radial formation to enable a common focus on one reaction tube among the three tubes. The ultraviolet LED excited FAM dyes in the sample tube. The fluorescence signal was measured by a detector unit consisting of a bandpass filter (D560; Chroma) and a photodiode (S130C; Thorlabs). The incidence angle was about 55°, which prevented direct illumination onto the detector unit. A stepper motor (17HS3430; MotionKing) rotated the wheel at angles of 120.6°, 120.6° and 118.8°, and another stepper motor (28BYJ-48; Elegoo) managed the positioning of 52-N-grade neodymium magnets (10 × 10 × 10 mm<sup>3</sup>) for MFS. A 3D-printed component holder firmly set the locations of the lasers, the stepper motor and the LED to keep them precisely aligned. A microcontroller board (Arduino Uno R3; Arduino) managed the continuous and sequential operation of the elements, and pulse-width modulation was adopted to control the synchronized actions (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">8</xref>). The power supply of the nanoPCR device was managed by the PWR button while the nanoPCR procedure was initiated by pushing the PCR button. The fluorescence emission was measured using a sensor read by an optical power console (PM400; Thorlabs). A 12-V Li-ion battery pack supplied the whole system, excluding the console, for over 30 min. All custom-made parts were fabricated using two different 3D printers (3DWOX DP201 (Sindoh) and Form 3 (Formlabs)), considering the manageable resolution and product dimensions.</p></sec><sec id="Sec13"><title>Clinical study</title><p id="Par31">The nasopharyngeal and oropharyngeal specimens collected in the universal transport medium tubes (Asan Pharmaceutical) and sputum specimens were provided by the Chonnam National University Hospital laboratory (Institutional Review Board number CNUH-2020-106) and processed using an automated nucleic acid extraction system (AdvanSure E3 System; LG Chem) to extract viral RNAs. Nasopharyngeal or oropharyngeal swabs contained in universal transport medium were used as provided, whereas sputum samples were diluted with phosphate buffered saline followed by an extraction process. For consistency of the assay, and to avoid any instrumental deviation, one nanoPCR machine was used to assay all of the clinical samples. The results were then compared with the RT–qPCR results, which were also performed using one machine. The analytical measures (<italic>F</italic>) for diagnostics were defined as <italic>F</italic><sub><italic>N1</italic></sub> = <italic>I</italic><sub><italic>N1</italic></sub>/<italic>I</italic><sub>HK</sub> (for <italic>N1</italic>) and <italic>F</italic><sub><italic>N2</italic></sub> = <italic>I</italic><sub><italic>N2</italic></sub>/<italic>I</italic><sub>HK</sub> (for <italic>N2</italic>), where <italic>I</italic><sub><italic>N1</italic></sub> and <italic>I</italic><sub><italic>N2</italic></sub> are the raw intensity values for the <italic>N1</italic> and <italic>N2</italic> tests, respectively, and <italic>I</italic><sub>HK</sub> is the fluorescence intensity of a positive control sample. ROC curves were generated using <italic>F</italic><sub><italic>N1</italic></sub> and <italic>F</italic><sub><italic>N2</italic></sub>. From the discovery cohort, the optimal <italic>F</italic> cut-offs for COVID-19 diagnostics were determined by choosing values that maximized the sum of sensitivity and specificity: <italic>F</italic><sub>TH_<italic>N1</italic></sub> = 0.152 (for <italic>N1</italic>) and <italic>F</italic><sub>TH_<italic>N2</italic></sub> = 0.053 (for <italic>N2</italic>). The analyses were performed using R (version 4.0.2).</p></sec><sec id="Sec14"><title>RT–qPCR of the clinical specimens</title><p id="Par32">Viral RNA of the clinical samples was added to the RT–PCR mix composed of 0.4 μM specific primers (IDT), 200 μM dNTP (New England Biolabs), 0.1 μM TaqMan probe (IDT), 1.25 U Hot Start Taq DNA Polymerase (New England Biolabs), 1.25 U FastGene Scriptase (NIPPON Genetics EUROPE), 1× Standard Taq Reaction Buffer (New England Biolabs) and Reverse Transcription Buffer (NIPPON Genetics EUROPE). RT–qPCR was then carried out and monitored on a ViiA 7 Real-Time PCR System (Life Technologies) with the following protocol: 94 °C for 2 min, then 50 cycles of 92 °C for 8 s, 58 °C for 22 s and 72 °C for 40 s. The Ct value was automatically calculated using the system software and was correlated with the result of nanoPCR.</p></sec><sec id="Sec15"><title>Gel electrophoresis</title><p id="Par33">In 1× TBE (Tris/Borate/EDTA) running buffer, the PCR product solution was resolved on a 3% agarose gel containing 1× SYBR Safe (Invitrogen) as a staining dye at a constant voltage of 120 V for 40 min. A gel image was taken with a ChemiDoc MP Imaging system (Bio-Rad).</p></sec><sec id="Sec16"><title>Statistical analysis</title><p id="Par34">All of the data are presented as means ± s.d. from experiments repeated at least five times unless otherwise specified. Where appropriate, three times the standard deviation, added onto background values, was used as a threshold value for significance.</p></sec><sec id="Sec17"><title>Reporting Summary</title><p id="Par35">Further information on research design is available in the <xref ref-type="supplementary-material" rid="MOESM2">Nature Research Reporting Summary</xref> linked to this article.</p></sec></sec></body><back><ack><title>Acknowledgements</title><p>We thank S.-Y. Cheon for graphic designs and illustrations of figures and POC devices. This work was supported by the Institute for Basic Science (IBS-R026-D1). H.L. was supported in part by US NIH grants R01CA229777, R21DA049577 and U01CA233360, US DOD-W81XWH1910199 and DOD-W81XWH1910194 and the MGH Scholar Fund.</p></ack><sec sec-type="author-contribution"><title>Author contributions</title><p>J. Cheong, H.Y., J.-H.L., H.L. and J. Cheon conceived of and designed the project. J. Cheong and J.-U.L. synthesized the MPNs and performed the material characterizations. H.-J.C. provided the clinical sample. J. Cheong and C.Y.L. conducted the PCR experiments. J. Cheong and H.Y. worked on the nanoPCR design and manufacturing. J. Cheong, H.Y., J.-H.L., H.L. and J. Cheon wrote the manuscript. All authors discussed the results and commented on the manuscript.</p></sec><sec sec-type="data-availability"><title>Data availability</title><p>The data that support the results of this study are available within the paper and its <xref ref-type="supplementary-material" rid="MOESM1">Supplementary Information</xref> files. The raw patient data are available from the authors on reasonable request, subject to approval from the Institutional Review Board of the Chonnam National University Hospital. Non-clinical data generated in this study, including source data and the data used to make the figures, are available in the <xref ref-type="supplementary-material" rid="MOESM1">Supplementary Information</xref> files.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1" sec-type="COI-statement"><title>Competing interests</title><p id="Par36">The authors declare no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>AK</given-names></name><name><surname>Hegde</surname><given-names>ST</given-names></name></person-group><article-title xml:lang="en">The important role of serology for COVID-19 control</article-title><source>Lancet Infect. Dis.</source><year>2020</year><volume>20</volume><fpage>758</fpage><lpage>759</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXnslekt74%3D</pub-id><pub-id pub-id-type="pmid">32330441</pub-id><pub-id pub-id-type="pmcid">7173803</pub-id><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30322-4</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>MP</given-names></name><etal/></person-group><article-title xml:lang="en">Diagnostic testing for severe acute respiratory syndrome-related coronavirus 2: a narrative review</article-title><source>Ann. Intern. Med.</source><year>2020</year><volume>172</volume><fpage>726</fpage><lpage>734</lpage><pub-id pub-id-type="pmid">32282894</pub-id><pub-id pub-id-type="doi">10.7326/M20-1301</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissleder</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Ko</surname><given-names>J</given-names></name><name><surname>Pittet</surname><given-names>MJ</given-names></name></person-group><article-title xml:lang="en">COVID-19 diagnostics in context</article-title><source>Sci. Transl. Med.</source><year>2020</year><volume>12</volume><fpage>eabc1931</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtFSqtrfF</pub-id><pub-id pub-id-type="pmid">32493791</pub-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abc1931</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Tong</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">Combination of RT‐qPCR testing and clinical features for diagnosis of COVID‐19 facilitates management of SARS‐CoV‐2 outbreak</article-title><source>J. Med. Virol.</source><year>2020</year><volume>92</volume><fpage>538</fpage><lpage>539</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXntlemu7s%3D</pub-id><pub-id pub-id-type="pmid">32096564</pub-id><pub-id pub-id-type="doi">10.1002/jmv.25721</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>CJ</given-names></name><name><surname>Ng</surname><given-names>CY</given-names></name><name><surname>Brook</surname><given-names>RH</given-names></name></person-group><article-title xml:lang="en">Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing</article-title><source>J. Am. Med. Assoc.</source><year>2020</year><volume>323</volume><fpage>1341</fpage><lpage>1342</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXnvVOjtbg%3D</pub-id><pub-id pub-id-type="doi">10.1001/jama.2020.3151</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salathé</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation</article-title><source>Swiss Med. Wkly</source><year>2020</year><volume>150</volume><fpage>w20225</fpage><pub-id pub-id-type="pmid">32191813</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilic</surname><given-names>T</given-names></name><name><surname>Weissleder</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Molecular and immunological diagnostic tests of COVID-19: current status and challenges</article-title><source>iScience</source><year>2020</year><volume>23</volume><fpage>101406</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhs1WrsL3N</pub-id><pub-id pub-id-type="pmid">32771976</pub-id><pub-id pub-id-type="pmcid">7381402</pub-id><pub-id pub-id-type="doi">10.1016/j.isci.2020.101406</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferretti</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing</article-title><source>Science</source><year>2020</year><volume>368</volume><fpage>eabb6936</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXovFCqsrY%3D</pub-id><pub-id pub-id-type="pmid">32234805</pub-id><pub-id pub-id-type="pmcid">7164555</pub-id><pub-id pub-id-type="doi">10.1126/science.abb6936</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krammer</surname><given-names>F</given-names></name><name><surname>Simon</surname><given-names>V</given-names></name></person-group><article-title xml:lang="en">Serology assays to manage COVID-19</article-title><source>Science</source><year>2020</year><volume>368</volume><fpage>1060</fpage><lpage>1061</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtFSqtLzP</pub-id><pub-id pub-id-type="pmid">32414781</pub-id><pub-id pub-id-type="doi">10.1126/science.abc1227</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Ainsworth, M. et al. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison. <italic>Lancet Infect. Dis.</italic><ext-link xlink:href="10.1016/S1473-3099(20)30634-4" ext-link-type="doi">https://doi.org/10.1016/S1473-3099(20)30634-4</ext-link> (2020).</mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitman</surname><given-names>JD</given-names></name><etal/></person-group><article-title xml:lang="en">Evaluation of SARS-CoV-2 serology assays reveals a range of test performance</article-title><source>Nat. Biotechnol.</source><year>2020</year><volume>38</volume><fpage>1174</fpage><lpage>1183</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhs12jtr7I</pub-id><pub-id pub-id-type="pmid">32855547</pub-id><pub-id pub-id-type="pmcid">7740072</pub-id><pub-id pub-id-type="doi">10.1038/s41587-020-0659-0</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Kasteren</surname><given-names>PB</given-names></name><etal/></person-group><article-title xml:lang="en">Comparison of commercial RT-PCR diagnostic kits for COVID-19</article-title><source>J. Clin. Virol.</source><year>2020</year><volume>128</volume><fpage>104412</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXpsVOlsLw%3D</pub-id><pub-id pub-id-type="pmid">32416600</pub-id><pub-id pub-id-type="pmcid">7206434</pub-id><pub-id pub-id-type="doi">10.1016/j.jcv.2020.104412</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">Review of the clinical characteristics of coronavirus disease 2019 (COVID-19)</article-title><source>J. Gen. Intern. Med.</source><year>2020</year><volume>35</volume><fpage>1545</fpage><lpage>1549</lpage><pub-id pub-id-type="pmid">32133578</pub-id><pub-id pub-id-type="pmcid">7088708</pub-id><pub-id pub-id-type="doi">10.1007/s11606-020-05762-w</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>LJ</given-names></name><etal/></person-group><article-title xml:lang="en">Assay techniques and test development for COVID-19 diagnosis</article-title><source>ACS Cent. Sci.</source><year>2020</year><volume>6</volume><fpage>591</fpage><lpage>605</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXotFCktLs%3D</pub-id><pub-id pub-id-type="pmid">32382657</pub-id><pub-id pub-id-type="pmcid">7197457</pub-id><pub-id pub-id-type="doi">10.1021/acscentsci.0c00501</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petralia</surname><given-names>S</given-names></name><name><surname>Conoci</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">PCR technologies for point of care testing: progress and perspectives</article-title><source>ACS Sens.</source><year>2017</year><volume>2</volume><fpage>876</fpage><lpage>891</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhtFagu7vI</pub-id><pub-id pub-id-type="pmid">28750519</pub-id><pub-id pub-id-type="doi">10.1021/acssensors.7b00299</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marx</surname><given-names>V</given-names></name></person-group><article-title xml:lang="en">PCR heads into the field</article-title><source>Nat. Methods</source><year>2015</year><volume>12</volume><fpage>393</fpage><lpage>397</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXnsVWnurw%3D</pub-id><pub-id pub-id-type="pmid">25924072</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.3369</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>SL</given-names></name><name><surname>George</surname><given-names>KS</given-names></name></person-group><article-title xml:lang="en">Evaluation of the COVID19 ID NOW EUA assay</article-title><source>J. Clin. Virol.</source><year>2020</year><volume>128</volume><fpage>104429</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXpsFygtLk%3D</pub-id><pub-id pub-id-type="pmid">32425657</pub-id><pub-id pub-id-type="pmcid">7227587</pub-id><pub-id pub-id-type="doi">10.1016/j.jcv.2020.104429</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>G-S</given-names></name><etal/></person-group><article-title xml:lang="en">Development of reverse transcription loop-mediated isothermal amplification (RT-LAMP) assays targeting SARS-CoV-2</article-title><source>J. Mol. Diagn.</source><year>2020</year><volume>22</volume><fpage>729</fpage><lpage>735</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXns1Wrsrc%3D</pub-id><pub-id pub-id-type="pmid">32276051</pub-id><pub-id pub-id-type="doi">10.1016/j.jmoldx.2020.03.006</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Ultrafast photonic PCR based on photothermal nanomaterials</article-title><source>Trends Biotechnol.</source><year>2020</year><volume>38</volume><fpage>637</fpage><lpage>649</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXisVeit77O</pub-id><pub-id pub-id-type="pmid">31918858</pub-id><pub-id pub-id-type="doi">10.1016/j.tibtech.2019.12.006</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Son</surname><given-names>JH</given-names></name><etal/></person-group><article-title xml:lang="en">Ultrafast photonic PCR</article-title><source>Light Sci. Appl.</source><year>2015</year><volume>4</volume><fpage>e280</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXht1Kiur%2FN</pub-id><pub-id pub-id-type="doi">10.1038/lsa.2015.53</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandolfi</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Ultrafast thermo-optical dynamics of plasmonic nanoparticles</article-title><source>J. Phys. Chem. C</source><year>2018</year><volume>122</volume><fpage>8655</fpage><lpage>8666</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXmt1Wgu7Y%3D</pub-id><pub-id pub-id-type="doi">10.1021/acs.jpcc.8b01875</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J-H</given-names></name><etal/></person-group><article-title xml:lang="en">Plasmonic photothermal gold bipyramid nanoreactors for ultrafast real-time bioassays</article-title><source>J. Am. Chem. Soc.</source><year>2017</year><volume>139</volume><fpage>8054</fpage><lpage>8057</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXmvVemsro%3D</pub-id><pub-id pub-id-type="pmid">28457135</pub-id><pub-id pub-id-type="doi">10.1021/jacs.7b01779</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donner</surname><given-names>JS</given-names></name><name><surname>Morales-Dalmau</surname><given-names>J</given-names></name><name><surname>Alda</surname><given-names>I</given-names></name><name><surname>Marty</surname><given-names>R</given-names></name><name><surname>Quidant</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Fast and transparent adaptive lens based on plasmonic heating</article-title><source>ACS Photonics</source><year>2015</year><volume>2</volume><fpage>355</fpage><lpage>360</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhvVOisLo%3D</pub-id><pub-id pub-id-type="doi">10.1021/ph500392c</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brolo</surname><given-names>AG</given-names></name></person-group><article-title xml:lang="en">Plasmonics for future biosensors</article-title><source>Nat. Photonics</source><year>2012</year><volume>6</volume><fpage>709</fpage><lpage>713</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38Xhs1ajsb7M</pub-id><pub-id pub-id-type="doi">10.1038/nphoton.2012.266</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Nam</surname><given-names>J-M</given-names></name></person-group><article-title xml:lang="en">Plasmonically engineered nanoprobes for biomedical applications</article-title><source>J. Am. Chem. Soc.</source><year>2016</year><volume>138</volume><fpage>14509</fpage><lpage>14525</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28Xhs1CgsLfJ</pub-id><pub-id pub-id-type="pmid">27723324</pub-id><pub-id pub-id-type="doi">10.1021/jacs.6b09451</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brongersma</surname><given-names>ML</given-names></name><name><surname>Halas</surname><given-names>NJ</given-names></name><name><surname>Nordlander</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Plasmon-induced hot carrier science and technology</article-title><source>Nat. Nanotechnol.</source><year>2015</year><volume>10</volume><fpage>25</fpage><lpage>34</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXislOrsw%3D%3D</pub-id><pub-id pub-id-type="pmid">25559968</pub-id><pub-id pub-id-type="doi">10.1038/nnano.2014.311</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndukaife</surname><given-names>JC</given-names></name><name><surname>Shalaev</surname><given-names>VM</given-names></name><name><surname>Boltasseva</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Plasmonics—turning loss into gain</article-title><source>Science</source><year>2016</year><volume>351</volume><fpage>334</fpage><lpage>335</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28Xhslyksr0%3D</pub-id><pub-id pub-id-type="pmid">26797997</pub-id><pub-id pub-id-type="doi">10.1126/science.aad9864</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Flexible thin-film black gold membranes with ultrabroadband plasmonic nanofocusing for efficient solar vapour generation</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>10103</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXitVWqs7jJ</pub-id><pub-id pub-id-type="pmid">26657535</pub-id><pub-id pub-id-type="doi">10.1038/ncomms10103</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>NJ</given-names></name><etal/></person-group><article-title xml:lang="en">Nanoparticles heat through light localization</article-title><source>Nano Lett.</source><year>2014</year><volume>14</volume><fpage>4640</fpage><lpage>4645</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhtVCru7zN</pub-id><pub-id pub-id-type="pmid">24960442</pub-id><pub-id pub-id-type="doi">10.1021/nl5016975</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Son</surname><given-names>JH</given-names></name><etal/></person-group><article-title xml:lang="en">Rapid optical cavity PCR</article-title><source>Adv. Healthc. Mater.</source><year>2016</year><volume>5</volume><fpage>167</fpage><lpage>174</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhvVOltr%2FP</pub-id><pub-id pub-id-type="pmid">26592501</pub-id><pub-id pub-id-type="doi">10.1002/adhm.201500708</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Nanoplasmonic on-chip PCR for rapid precision molecular diagnostics</article-title><source>ACS Appl. Mater. Interfaces</source><year>2020</year><volume>12</volume><fpage>12533</fpage><lpage>12540</lpage><pub-id pub-id-type="pmid">32101396</pub-id><pub-id pub-id-type="doi">10.1021/acsami.9b23591</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXjvVGltr4%3D</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanzha</surname><given-names>E</given-names></name><etal/></person-group><article-title xml:lang="en">Gold nanoparticle-assisted polymerase chain reaction: effects of surface ligands, nanoparticle shape and material</article-title><source>RSC Adv.</source><year>2016</year><volume>6</volume><fpage>110146</fpage><lpage>110154</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhvVCiurvI</pub-id><pub-id pub-id-type="doi">10.1039/C6RA20472D</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Jon</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Gold nanorod-based photo-PCR system for one-step, rapid detection of bacteria</article-title><source>Nanotheranostics</source><year>2017</year><volume>1</volume><fpage>178</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">29071186</pub-id><pub-id pub-id-type="pmcid">5646718</pub-id><pub-id pub-id-type="doi">10.7150/ntno.18720</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swierczewska</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">The design and application of fluorophore–gold nanoparticle activatable probes</article-title><source>Phys. Chem. Chem. Phys.</source><year>2011</year><volume>13</volume><fpage>9929</fpage><lpage>9941</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXmtFyksLc%3D</pub-id><pub-id pub-id-type="pmid">21380462</pub-id><pub-id pub-id-type="pmcid">3632443</pub-id><pub-id pub-id-type="doi">10.1039/c0cp02967j</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morozov</surname><given-names>VN</given-names></name><name><surname>Kolyvanova</surname><given-names>MA</given-names></name><name><surname>Dement’eva</surname><given-names>OV</given-names></name><name><surname>Rudoy</surname><given-names>VM</given-names></name><name><surname>Kuzmin</surname><given-names>VA</given-names></name></person-group><article-title xml:lang="en">Fluorescence superquenching of SYBR Green I in crowded DNA by gold nanoparticles</article-title><source>J. Lumin.</source><year>2020</year><volume>219</volume><fpage>116898</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXit1ektrbN</pub-id><pub-id pub-id-type="doi">10.1016/j.jlumin.2019.116898</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhs1Kqu7c%3D</pub-id><pub-id pub-id-type="pmid">31986264</pub-id><pub-id pub-id-type="pmcid">7159299</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J-w</given-names></name><etal/></person-group><article-title xml:lang="en">Single-cell mechanogenetics using monovalent magnetoplasmonic nanoparticles</article-title><source>Nat. Protoc.</source><year>2017</year><volume>12</volume><fpage>1871</fpage><lpage>1889</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhtlGksbnI</pub-id><pub-id pub-id-type="pmid">28817122</pub-id><pub-id pub-id-type="pmcid">5742362</pub-id><pub-id pub-id-type="doi">10.1038/nprot.2017.071</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baffou</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Photoinduced heating of nanoparticle arrays</article-title><source>ACS Nano</source><year>2013</year><volume>7</volume><fpage>6478</fpage><lpage>6488</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXhtFOqtbvP</pub-id><pub-id pub-id-type="pmid">23895209</pub-id><pub-id pub-id-type="doi">10.1021/nn401924n</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Abajo</surname><given-names>FG</given-names></name><name><surname>Howie</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Retarded field calculation of electron energy loss in inhomogeneous dielectrics</article-title><source>Phys. Rev. B</source><year>2002</year><volume>65</volume><fpage>115418</fpage><pub-id pub-id-type="doi">10.1103/PhysRevB.65.115418</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD38XitVejsr8%3D</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>PK</given-names></name><name><surname>El-Sayed</surname><given-names>MA</given-names></name></person-group><article-title xml:lang="en">Plasmonic coupling in noble metal nanostructures</article-title><source>Chem. Phys. Lett.</source><year>2010</year><volume>487</volume><fpage>153</fpage><lpage>164</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXit1SgtbY%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cplett.2010.01.062</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kralik</surname><given-names>P</given-names></name><name><surname>Ricchi</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">A basic guide to real time PCR in microbial diagnostics: definitions, parameters, and everything</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>108</fpage><pub-id pub-id-type="pmid">28210243</pub-id><pub-id pub-id-type="pmcid">5288344</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.00108</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forootan</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Methods to determine limit of detection and limit of quantification in quantitative real-time PCR (qPCR)</article-title><source>Biomol. Detect. Quantif.</source><year>2017</year><volume>12</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXmvFSmtLs%3D</pub-id><pub-id pub-id-type="pmid">28702366</pub-id><pub-id pub-id-type="pmcid">5496743</pub-id><pub-id pub-id-type="doi">10.1016/j.bdq.2017.04.001</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="other"><italic>COVID-19 Target Product Profiles for Priority Diagnostics to Support Response to the COVID-19 Pandemic v.1.0</italic> R&amp;D Blueprint (World Health Organization, 2020); <ext-link xlink:href="https://www.who.int/publications/m/item/covid-19-target-product-profiles-for-priority-diagnostics-to-support-response-to-the-covid-19-pandemic-v.0.1" ext-link-type="uri">https://www.who.int/publications/m/item/covid-19-target-product-profiles-for-priority-diagnostics-to-support-response-to-the-covid-19-pandemic-v.0.1</ext-link></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyrlaki</surname><given-names>I</given-names></name><etal/></person-group><article-title xml:lang="en">Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR</article-title><source>Nature Comm.</source><year>2020</year><volume>11</volume><fpage>4812</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhvFOhsrfL</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-18611-5</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roda</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Smartphone-based biosensors: a critical review and perspectives</article-title><source>Trends Analyt. Chem.</source><year>2016</year><volume>79</volume><fpage>317</fpage><lpage>325</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhvF2msrbI</pub-id><pub-id pub-id-type="doi">10.1016/j.trac.2015.10.019</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Trends in miniaturized biosensors for point-of-care testing</article-title><source>Trends Analyt. Chem.</source><year>2020</year><volume>122</volume><fpage>115701</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXitVelsrfJ</pub-id><pub-id pub-id-type="doi">10.1016/j.trac.2019.115701</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Schalkwyk</surname><given-names>C</given-names></name><name><surname>Maritz</surname><given-names>J</given-names></name><name><surname>Van Zyl</surname><given-names>GU</given-names></name><name><surname>Preiser</surname><given-names>W</given-names></name><name><surname>Welte</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Pooled PCR testing of dried blood spots for infant HIV diagnosis is cost efficient and accurate</article-title><source>BMC Infect. Dis.</source><year>2019</year><volume>19</volume><pub-id pub-id-type="pmid">30744605</pub-id><pub-id pub-id-type="pmcid">6371519</pub-id><pub-id pub-id-type="doi">10.1186/s12879-019-3767-z</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devonshire</surname><given-names>AS</given-names></name><etal/></person-group><article-title xml:lang="en">The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis</article-title><source>BMC Infect. Dis.</source><year>2016</year><volume>16</volume><pub-id pub-id-type="pmid">27487852</pub-id><pub-id pub-id-type="pmcid">4971652</pub-id><pub-id pub-id-type="doi">10.1186/s12879-016-1696-7</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhslartLvI</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Probert</surname><given-names>WS</given-names></name><name><surname>Hacker</surname><given-names>JK</given-names></name></person-group><article-title xml:lang="en">New subgenotyping and consensus real-time reverse transcription-PCR assays for hepatitis A outbreak surveillance</article-title><source>J. Clin. Microbiol.</source><year>2019</year><volume>57</volume><fpage>e00500</fpage><lpage>e00519</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhs1yqs7Y%3D</pub-id><pub-id pub-id-type="pmid">31217273</pub-id><pub-id pub-id-type="pmcid">6711912</pub-id><pub-id pub-id-type="doi">10.1128/JCM.00500-19</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waxenegger</surname><given-names>J</given-names></name><name><surname>Trügler</surname><given-names>A</given-names></name><name><surname>Hohenester</surname><given-names>U</given-names></name></person-group><article-title xml:lang="en">Plasmonics simulations with the MNPBEM toolbox: consideration of substrates and layer structures</article-title><source>Comput. Phys. Commun.</source><year>2015</year><volume>193</volume><fpage>138</fpage><lpage>150</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXmvFajtr0%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cpc.2015.03.023</pub-id></mixed-citation></ref></ref-list></ref-list><app-group><app id="App1" specific-use="web-only"><sec id="Sec18"><title>Supplementary information</title><p id="Par37"><supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary information"><media mimetype="application" mime-subtype="pdf" xlink:href="MediaObjects/41551_2020_654_MOESM1_ESM.pdf" position="anchor"><label>Supplementary Information</label><caption xml:lang="en"><p>Supplementary figures, tables and discussion.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2" xlink:title="Supplementary information"><media mimetype="application" mime-subtype="pdf" xlink:href="MediaObjects/41551_2020_654_MOESM2_ESM.pdf" position="anchor"><caption xml:lang="en"><p>Reporting Summary</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3" xlink:title="Supplementary information"><media mimetype="video" mime-subtype="mp4" xlink:href="MediaObjects/41551_2020_654_MOESM3_ESM.mp4" position="anchor"><label>Supplementary Video 1</label><caption xml:lang="en"><p>Overall workflow of the nanoPCR device, showing the use of the RNA preparation kit followed by nanoPCR nucleic acid amplification, all within 17 min.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM4" xlink:title="Supplementary information"><media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="MediaObjects/41551_2020_654_MOESM4_ESM.xlsx" position="anchor"><label>Supplementary Data 1</label><caption xml:lang="en"><p>Raw data for each main figure.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM5" xlink:title="Supplementary information"><media mimetype="application" mime-subtype="msword" xlink:href="MediaObjects/41551_2020_654_MOESM5_ESM.docx" position="anchor"><label>Supplementary Code 1</label><caption xml:lang="en"><p>Source code for the operation of the nanoPCR device.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM6" xlink:title="Supplementary information"><media mimetype="application" mime-subtype="msword" xlink:href="MediaObjects/41551_2020_654_MOESM6_ESM.docx" position="anchor"><label>Supplementary Code 2</label><caption xml:lang="en"><p>Header file for the source code.</p></caption></media></supplementary-material></p></sec></app></app-group><notes notes-type="ESMHint"><title>Supplementary information</title><p>is available for this paper at <ext-link xlink:href="10.1038/s41551-020-00654-0" ext-link-type="doi">https://doi.org/10.1038/s41551-020-00654-0</ext-link>.</p></notes><notes notes-type="Misc"><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes><notes notes-type="Misc"><p><bold>Peer review information</bold><italic>Nature Biomedical Engineering</italic> thanks the anonymous reviewer(s) for their contribution to the peer review of this work.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Biomedical Engineering/Biotechnology</facet-value><facet-value count="1">Biomedicine</facet-value><facet-value count="1">Biomedicine, general</facet-value></facet><facet name="keyword"/><facet name="pub"><facet-value count="1">Nature Biomedical Engineering</facet-value></facet><facet name="year"><facet-value count="1">2020</facet-value></facet><facet name="country"><facet-value count="1">South Korea</facet-value><facet-value count="1">United States</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
